Key facts
- This page summarizes Timothy P. Zannes's Form 4 filing for bioAffinity Technologies, Inc. (BIAF).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2024, 16:00.
Timothy P. Zannes - 04 Apr 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)
- Reporting relationship
- Secretary, EVP, Gen. Counsel
- Issuer ticker
- BIAF
- Reported as of
- 04 Apr 2024
- Net transaction value
- +$324
- SEC form
- 4
- Accepted by SEC
- 24 Apr 2024, 16:00:23 UTC
- Prior SEC filing
- 02 Feb 2024
- Next SEC filing
- 14 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maria Zannes, as attorney-in-fact for Timothy P. Zannes
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy P. Zannes filed Form 4 for bioAffinity Technologies, Inc. (BIAF) on 24 Apr 2024.
Change
- Previous filing in this sequence was filed on 02 Feb 2024.
- Current net transaction value: +$324.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIAF
transaction
Common Stock
Options Exercise
- Transaction value
- $75,224
- Shares
- +64,848
- Change %
- +629%
- Price
- $1.16
- Shares after
- 75,155
- Date
- 04 Apr 2024
- Ownership
- Direct
BIAF
transaction
Common Stock
Tax liability
- Transaction value
- $74,900
- Shares
- -29,031
- Change %
- -39%
- Price
- $2.58
- Shares after
- 46,124
- Date
- 04 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIAF
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -64,848
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,848
- Exercise price
- $1.16
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares withheld to cover the exercise price of the options exercised.
Footnote F2
This option vested in 7 equal monthly installments beginning on April 28, 2014.